menu
    • menu
    [{"orgOrder":0,"company":"Pooyesh Darou Biopharmaceutical Co.","sponsor":"Pooyesh Darou Biopharmaceutical Co.","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"IRAN","productType":"Protein","year":"2016","type":"Inapplicable","leadProduct":"ERYTHROPOIETIN","moa":"Erythropoietin receptor","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Pooyesh Darou Biopharmaceutical Co.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pooyesh Darou Biopharmaceutical Co. \/ Pooyesh Darou Biopharmaceutical Co.","highestDevelopmentStatusID":"1","companyTruncated":"Pooyesh Darou Biopharmaceutical Co. \/ Pooyesh Darou Biopharmaceutical Co."}]

    Find Clinical Drug Pipeline Developments & Deals by Pooyesh Darou Biopharmaceutical Co.

    Menu

    Pooyesh Darou Biopharmaceutical Co.

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Pooyesh Darou Biopharmaceutical Co.

                            Iran arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Pooyesh Darou Biopharmaceutical Co.

                            Iran arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : ERYTHROPOIETIN

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Recipient : Shahid Beheshti University of Medical Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery

                            Details : Erythropoietin is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Myocardial Reperfusion Injury.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            December 06, 2016

                            Lead Product(s) : ERYTHROPOIETIN

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Recipient : Shahid Beheshti University of Medical Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth